Products with Anti-inflammatory bioactivity

Cat.No. Product Name
BCN3412 Astringin
1. Astringinin is a potent antiarrhythmic agent with cardioprotective activity in ischemic and ischemic-reperfused rat heart, the beneficial effects of astringinin in the ischemic and ischemic-reperfused hearts may be correlated with its antioxidant activity and upregulation of NO production. 2. Astringinin can significantly attenuate proinflammatory responses and hepatic injury after trauma-hemorrhage, the salutary effects of astringinin administration on attenuation of hepatic injury following trauma-hemorrhage are likely due to reduction of pro-inflammatory mediator levels.
BCN3432 Chikusetsusaponin IVa
Chikusetsusaponin IVa is a novel AMPK activator, can induce insulin secretion from βTC3 cells via GPR40 mediated calcium and PKC pathways, may be developed into a new potential for therapeutic agent used in T2DM patients.Chikusetsusaponin IVa exerts antithrombotic effects, including minor hemorrhagic events.
BCN3451 2-Anthraquinonecarboxylic acid
Anthraquinone-2-carboxylic acid is a novel electron shuttling mediator, shows potent anti-inflammatory and antinociceptive activities in vivo, thus contributing to the immune regulatory role of fruits and herbs.
BCN3468 Skimmianin
1. Skimmianine is a new inhibitor against the Leishmania APRT enzyme. 2. Skimmianine has a selective inhibitory effect on the 5-hydroxytryptamine-induced vasopressor responses of rats. 3, Skimmianine is a strong acetylcholinesterase (AChE) inhibitor. 4. Skimmianine has anti-inflammatory properties. 5. Skimmianine has leishmanicidal effect , it is thus a promising drug candidate for L. braziliensis due to its potent immunomodulatory activity.
BCN3508 1beta-Hydroxyalantolactone
1. 1beta-Hydroxyalantolactone has protective effect against AD-like skin inflammation, can as a potential therapeutic agent for AD.

Items 501 to 505 of 797 total